Author

F. IZARD

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Ma· 1 shared C. Bellanger· 1 shared C. Gourzones· 1 shared C. Grimaud· 1 shared E. De Bruyne· 1 shared E. Desmedt· 1 shared E. JULIEN· 1 shared G. Cartron· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ma

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma

L. Herviou, F. IZARD, O. Karmous-Gadacha, C. Gourzones, C. Bellanger, E. Desmedt, A. Ma, L. Vincent, G. Cartron, J. Jin, E. De Bruyne, C. Grimaud, E. JULIEN, J. Moreaux

This study shows that inhibiting SETD8 reduces multiple myeloma cell survival and overcomes drug resistance regardless of p53 status.

bioRxiv · Sep 20, 2019Cancer Biology